Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK.
IQVIA, London, UK.
Patient. 2022 Jul;15(4):459-472. doi: 10.1007/s40271-021-00563-7. Epub 2021 Dec 23.
Assistive reproductive therapies can help those who have difficulty conceiving but different forms of assistive reproductive therapies are associated with different treatment characteristics. We undertook a large, multinational discrete choice experiment to understand patient preferences for assistive reproductive therapies.
We administered an online discrete choice experiment with persons who had experience with subfertility or assistive reproductive therapies in the USA, UK, the Nordic region (Denmark, Norway, Sweden, Finland), Spain, and China. Attributes encouraged trade-offs between effectiveness, risk of adverse effects, treatment (dis)comfort, (in)convenience, cost per cycle and shared decision making. We used multinomial logit and mixed-logit models to estimate preferences and attribute importance by country/region, and estimated willingness to pay for changes in attribute levels.
A total of 7565 respondents participated. Mixed logit had a better fit than multinomial logit across all samples. Preferences moved in expected directions across all samples, but the relative importance of attributes differed between countries. Willingness to pay was greatest for improvements in effectiveness and a greater degree of shared decision making, and we observe a substantial 'option value' independent of treatment characteristics. Unexpectedly, preferences over cost were insignificant in the Chinese sample, limiting the use of willingness to pay in this sample.
Respondents balanced concerns for effectiveness with other considerations, including the cost and (dis)comfort of treatment, and the degree of shared decision making, but there is also substantial option value independent of treatment characteristics, demonstrating value of assistive reproductive therapies to individuals with experience of subfertility. We hypothesise that price insensitivity in the Chinese sample may reflect a degree of social desirability bias.
辅助生殖技术可以帮助那些难以受孕的人,但不同形式的辅助生殖技术具有不同的治疗特点。我们进行了一项大型的、多国家的离散选择实验,以了解患者对辅助生殖技术的偏好。
我们在美国、英国、北欧地区(丹麦、挪威、瑞典、芬兰)、西班牙和中国的亚生育或辅助生殖治疗经验者中开展了一项在线离散选择实验。属性鼓励在有效性、不良反应风险、治疗(不适)舒适性、(不便)性、每个周期的成本和共同决策之间进行权衡。我们使用多项逻辑和混合逻辑模型来估计偏好和属性的重要性,并按国家/地区估计对属性水平变化的支付意愿。
共有 7565 名受访者参与。混合逻辑在所有样本中都比多项逻辑具有更好的拟合度。在所有样本中,偏好都朝着预期的方向移动,但属性的相对重要性在国家之间存在差异。对提高有效性和更大程度的共同决策的支付意愿最大,并且我们观察到与治疗特征无关的实质性“选择价值”。出乎意料的是,在中国样本中,对成本的偏好并不显著,限制了在该样本中使用支付意愿。
受访者在关注有效性的同时,还考虑了其他因素,包括治疗的成本和(不适)舒适性,以及共同决策的程度,但也存在与治疗特征无关的实质性选择价值,这表明辅助生殖技术对经历过亚生育的个人具有价值。我们假设中国样本中对价格不敏感可能反映了一定程度的社会期望偏差。